Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-29.89
Price to sales ratio
503.83

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1590
OGN
Organon & Co. Common Stock
13.50 USD0.00%0.00%+0.37%+85.95%3.55 B USD
1788
MBX
MBX Biosciences, Inc. - Common Stock
59.31 USD+4.81%-4.86%+50.72%+323.64%2.82 B USD
2009
RAPP
Rapport Therapeutics, Inc. - Common Stock
40.51 USD-2.29%+1.76%+5.39%+54.68%1.94 B USD
2059
GENB
Generate Biomedicines, Inc. - Common Stock
13.69 USD-3.66%-13.19%+1.71%-8.73%1.75 B USD

Frequently asked questions about Palvella Therapeutics, Inc. - Common Stock

What is the Palvella Therapeutics, Inc. - Common Stock stock price today?

The current price of Palvella Therapeutics, Inc. - Common Stock (PVLA) is 154.34. Over the past 24 hours, the stock has changed by +3.11%. Follow the PVLA chart for real-time price dynamics.

What is the stock ticker of Palvella Therapeutics, Inc. - Common Stock?

Palvella Therapeutics, Inc. - Common Stock trades under the ticker PVLA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Palvella Therapeutics, Inc. - Common Stock stock going up?

PVLA has changed by +8.97% over the last week, +31.91% over the last month, and +108.99% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Palvella Therapeutics, Inc. - Common Stock net income for the last quarter?

Palvella Therapeutics, Inc. - Common Stock reported net income of -15.77 M for the last quarter. The previous quarter showed -12.71 M, which means net income changed by -24.01%.

How many employees does Palvella Therapeutics, Inc. - Common Stock have?

As of the latest available data, Palvella Therapeutics, Inc. - Common Stock has 29 employees. Workforce size can provide additional context about the company's scale and operations.

What is Palvella Therapeutics, Inc. - Common Stock EBITDA?

Palvella Therapeutics, Inc. - Common Stock EBITDA is -13.8 M, and its EBITDA margin is -1 285.83%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Palvella Therapeutics, Inc. - Common Stock stock?

You can buy Palvella Therapeutics, Inc. - Common Stock (PVLA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Palvella Therapeutics, Inc. - Common Stock stock?

Investing in Palvella Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PVLA chart and related analysis on metatrader.com as part of your research.